bmiMD GLP-1 Telehealth (Semaglutide / Tirzepatide) vs Marek Health Guided Optimization Membership
Specs, prices, editor verdict, and who should buy which - compared side-by-side.
bmiMD GLP-1 Telehealth (Semaglutide / Tirzepatide) (mid, $289–$499/mo) vs Marek Health Guided Optimization Membership (premium, $99–$399/mo) - different tools for different jobs (see the per-product details below).
Compared on 1 shared spec · cross-category comparison (ai software vs diagnostic).
These are close picks. Both score in the same range. The right call depends on buyer profile - read the per-buyer recommendations below.
Side-by-side specs
| Spec | bmiMD GLP-1 Telehealth (Semaglutide / Tirzepatide) | Marek Health Guided Optimization Membership |
|---|---|---|
| price | $289–$499/mo | $99–$399/mo |
| medications | Semaglutide, Tirzepatide (compounded) | Testosterone, HCG, anastrozole, enclomiphene, peptides, ancillaries |
bmiMD GLP-1 Telehealth (Semaglutide / Tirzepatide) also publishes: cadence, delivery, oversight, cookie
Marek Health Guided Optimization Membership also publishes: serviceType, deliveryModel, biomarkers, membership, initialPanel, consultModel, audience, monitoringCadence
Who should buy which
Buyers ready for GLP-1 medical intervention who want telehealth access at meaningfully lower cost than retail Wegovy / Mounjaro, with included physician oversight and titration support.
You're unsure GLP-1 is the right intervention - start with diet + exercise + lab work first. Or you have insurance coverage for retail Wegovy / Mounjaro (run those through insurance instead).
Experienced TRT/HRT users running multi-medication protocols, biomarker-literate buyers who want clinically aggressive guidance, and the intersection of "performance optimization" and "wants real bloodwork supervision."
You're TRT-curious for the first time (start with Hone), you can't budget $300+/mo all-in, or you want a higher-touch in-clinic experience (Defy Medical or Cenegenics).